Hepatic tumours during androgen therapy in Fanconi anaemia
β Scribed by R. L. Touraine; Y. Bertrand; P. Foray; J. Gilly; N. Philippe
- Publisher
- Springer
- Year
- 1993
- Tongue
- English
- Weight
- 329 KB
- Volume
- 152
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Two types of cytomembranous abnormalities were identified for the first time in liver biopsies from patients with chronic active type B hepatitis during treatment with recombinant a-interferon. Tubuloreticular inclusions were present in the hepatic endothelial cells, Kupffer cells and perisinusoidal
Our data support the findings of Wieckowska et al. 2 in demonstrating that measuring serum CK-18 fragments level could potentially be used as a noninvasive diagnostic test to predict the severity of NAFLD; however, before the liver biopsy is abandoned altogether, verification of the noninvasive diag
## Abstract Androgen deprivation therapy (ADT) for prostate cancer increases fracture risk, decreases bone mineral density, and increases bone turnover markers (BTMs) including serum type 1 Cβtelopeptide (sCTX), tartrateβresistant alkaline phosphatase 5b (TRAPβ5b), and procollagenβ1 Nβterminal telo